Healthcare

ImExHS Limited (ASX:IME)

Industry Group : Health Care Equipment & Services | Industry Group Name : Health Care Technology

Market Price : AUD 1.4250 (0%)

(as on 2021-09-26 08:55:38)

Market Cap : AUD 43.391 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
1.425 1.39 1.425 1.39L 1.425 H 1.36L 2.54 H
Last Trade 1.425
Change% 0.0000
52 W H/L 2.54/1.36
EBITDA -2.233 M
NPAT After Abnormal Items -3.616 M
Equity 15.536 M
ROE% -23.27%
Total Liabilities 5.268 M
Total Revenue 10.982 M
Cash and Cash Equivalents 10.796 M

Stock Information

Share price 1.425
Market Cap 43.391 M
Price/Gross Cash Flow -77.62
Dividend Yield Excluding Special 0.00%
Ending Shares 29.7 M
52-Week Range 1.36-2.54
P/E ratio 0.000
Sector P/E --
EPS -14.62
EV/EBITDA --
Net Profit Margin (%) -33.13%
Gross Cash Flows Per Share -0.02
Net Gearing -58.56%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.49
Sales Per Share 0.44
Book Value Per Share 0.52

Announcements

Heading Date/Time
Application for quotation of securities - IME  23/09/2021 4:06PM
Appendix 3Y - Douglas Lingard  23/09/2021 3:55PM
Application for quotation of securities - IME  21/09/2021 3:51PM
Appendix 3Y - Douglas Flynn  21/09/2021 3:28PM
Appendix 3Y - Damian Banks  21/09/2021 3:27PM
Appendix Y - Douglas Flynn  17/09/2021 3:58PM
Appendix 3Y - Douglas Flynn  14/09/2021 6:37PM
Appendix 3Y - Douglas Lingard  09/09/2021 11:59AM
Appendix 3Y - Douglas Flynn  02/09/2021 3:23PM
Appendix 3Y - Damian Banks  02/09/2021 3:23PM
Notice of Extraordinary General Meeting/Proxy Form  01/09/2021 12:38PM
Investor Presentation - 1H FY21 Results  30/08/2021 10:17AM
IMEXHS reports 1H FY21 Financial Results  30/08/2021 10:14AM
Half Yearly Report and Accounts  30/08/2021 10:11AM
Notice of 1HFY21 Conference Call  16/08/2021 6:03PM
Becoming a substantial holder  13/08/2021 2:37PM
Appendix 3Y - Damian Banks  11/08/2021 11:12AM
Appendix 3Y - Douglas Flynn  04/08/2021 3:20PM
2021 Q2 Activity Report and Appendix 4C  30/07/2021 10:03AM
Proposed issue of securities - IME  26/07/2021 9:30AM
Proposed issue of securities - IME  26/07/2021 9:25AM
Investor Presentation - RIMAB SAS  26/07/2021 8:50AM
Acquisition of radiology service provider RIMAB SAS  26/07/2021 8:45AM
Aquila in the Clouds strongest quarter  08/07/2021 10:37AM
Expiry of Unlisted Options  02/07/2021 8:55AM
Appendix 3Y - Carlos Palacio  14/05/2021 2:21PM
Appendix 3Y - Douglas Lingard  14/05/2021 2:19PM
Appendix 3Y - Damian Banks  14/05/2021 2:19PM
Appendix 3Y - Douglas Flynn  14/05/2021 2:19PM

Similar Companies

Related Articles

About Company

ImExHS Limited (ASX: IME) The company is engaged in providing leading medical imaging software to healthcare facilities. The official listing year is 2005, and the company is based in O’Riordan Street, Mascot, Australia. The company falls under the information technology sector and software & services industry group.

Corporate Information

company address 122 O'Riordan Street, MASCOT, NSW, AUSTRALIA, 2020

company phone+61 2 9030 0040

company websitehttp://www.imexhs.com

Dividends

Ex-Dividend Date Franking DPS (AUD) Dividend Yield
30/12/2020 -- 0.000 0.00%
30/12/2019 -- 0.000 0.00%
30/12/2018 -- 0.000 0.00%
30/12/2017 -- 0.000 0.00%
30/12/2016 -- 0.000 0.00%
30/12/2015 -- 0.000 0.00%
30/12/2014 -- 0.000 0.00%
30/12/2013 -- 0.000 0.00%
30/12/2012 -- 0.000 0.00%
30/12/2011 -- 0.000 0.00%

Event Calendar

Event Type Event Date Event Year
Report (Interim) 2022-08-29 2022
Report (Annual) 2022-03-28 2022
Report (Prelim) 2022-02-25 2022
Issued Shares 2021-09-27 2021

Financials

Breakdown 30/12/2020 30/12/2019 30/12/2018 30/12/2017 30/12/2016
Trading Revenue 10.914 M 7.727 M 5.78 M -- 80,117
Other Revenue 67,674 0 0 742,426 0
Total Revenue 10.982 M 7.727 M 5.78 M 742,426 80,117
Interest Income 20,068 142,554 307,129 10,193 34,594
Interest Expenses -1.205 M -899,521 -528,129 0 0
Expenses -12.301 M -12.187 M -6.635 M -857,622 -4.064 M
EBITDA -1.319 M -4.46 M -854,840 -115,196 -3.984 M
Depreciation and Amortization -1.024 M -825,929 -306,711 -10,990 -20,806
Depreciation -814,862 -825,929 -179,052 -10,990 -20,806
Amortisation -209,524 0 -127,659 0 0
EBIT -2.343 M -5.286 M -1.162 M -126,186 -4.005 M
Pre Tax Profit -3.528 M -6.043 M -1.383 M -115,993 -3.97 M
Tax Expense -87,889 40,343 -91,818 0 0
Net Profit After Tax -3.616 M -6.002 M -1.474 M -115,993 -3.97 M
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items 0 0 -3.413 M 184,462 -520,816
Reported Net Profit After Abnormal Items -3.616 M -6.002 M -4.887 M 68,469 -4.491 M
Ending Shares 29.7 M 1.176 B 925.657 M 150.657 M 11.328 M
Weighted Average Shares 24.73 M 954.082 M 658.924 M 95.249 M 11.328 M
EPS After Abnormal Items (cents) -14.62 -0.63 -0.74 0.07 -39.64
Breakdown 30/12/2020 30/12/2019 30/12/2018 30/12/2017 30/12/2016
Total Current Assets 15.245 M 10.911 M 7.137 M 1.541 M 348,376
Total Non Current Assets 5.559 M 3.887 M 2.118 M 7,035 147,676
Total Assets 20.804 M 14.797 M 9.256 M 1.548 M 496,052
Total Current Liabilities 4.459 M 3.654 M 3.323 M 89,093 822,152
Total Non Current Liabilities 809,228 826,894 82,223 0 0
Total Liabilities 5.268 M 4.481 M 3.405 M 89,093 822,152
Net Assets 15.536 M 10.317 M 5.851 M 1.459 M -326,100
Breakdown 30/12/2020 30/12/2019 30/12/2018 30/12/2017 30/12/2016
Net Operating Cash -1.467 M -4.09 M -1.969 M -696,430 -3.651 M
Net Invested Cash -2.186 M -2.46 M -1.323 M 0 -29,706
Net Financing Cash Flows 7.405 M 11.28 M 5.69 M 1.473 M 244,400
End Cash Position 10.796 M 7.15 M 2.445 M 963,959 187,739
Beginning Cash 7.15 M 2.445 M 4,593 187,739 3.625 M
Exchange Rate Adjustments -104,567 -24,975 42,836 0 0
Other Cash Adjustments 0 0 0 0 0
Ending Cash 10.796 M 7.15 M 2.445 M 963,959 187,739

© 2021 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ) at www.morningstar.com.au/s/fsg.pdf and www.morningstar.com.au/s/fapds.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Some material is copyright and published under license from ASX Operations Pty Ltd ACN 004 523 782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK